Relmada Therapeutics, Inc. (RLMD): Weighted Average Diluted Shares
Annual figures by period end, from SEC filings.
Stock splits: 1-for-5, first reflected in a filing dated 2015-09-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.
39.48M
Year ended 2025-12-31
+10.0%
3-year compound annual growth
2021-12-31Weighted Average Diluted Shares (shares)2025-12-31